About Eileen Carry
Form D filings for Zena Therapeutics in 2023 list Eileen Carry as chief scientific officer and director.
Eileen Carry first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Eileen Carry in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Eileen Carry works with at each company, as listed on that company's latest Form D.
Zena Therapeutics Inc. · Form D, Sep 7, 2023
AV
Ariane Vasilatis
Executive officer and director